Magnesium Chloride
Subpotent drug
Yes — there is an active recall. 21 ongoing FDA recalls mention Magnesium (165 total). Check the affected lots below.
Most common reason: Sterility / contamination (64 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Magnesium. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Subpotent drug
Product mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actually contained an IV bag of Tranexamic Acid instead.
Failed Disintegration Specifications: above the time expected.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.
Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.
Labeling: Not Elsewhere Classified - Wrong NDC number
This product is being recalled due to the tube weld failure presents itself as a slow leak and can be difficult to detect.
Microbial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteria
Microbial Contamination of Non-Sterile Products - Presence of Acetobacter nitrogenifigens bacteria
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
Failed Impurities/Degradation Specifications:Out of Specification result reported for the test of organic impurities for the drug product,at the 18 month time point in long term stability study (25¿C/60% RH).
Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Lack of sterility assurance
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
CGMP Deviations;
CGMP Deviations
CGMP Deviations
Microbial contamination of non-sterile products.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.